The Essential guide to Flash CS4

Por Kerr, Cheridan., Keats, Jonathan.
Publicado em 2009

Glucocorticoid Receptor Expression in Multiple Myeloma Patients is a Predictor of Survival

Por Pozhitkov, Alexander, Rosenzweig, Michael, Pichiorri, Flavia, Gunes, Emine G., Buettner, Ralf, Keats, Jonathan J., Rosen, Steven T.
Publicado no Leuk Lymphoma (2020)

Classical and/or alternative NF-κB pathway activation in multiple myeloma

Por Demchenko, Yulia N., Glebov, Oleg K., Zingone, Adriana, Keats, Jonathan J., Bergsagel, P. Leif, Kuehl, W. Michael
Publicado em 2010

Molecular Mechanisms of Bortezomib Resistant Adenocarcinoma Cells

Por Suzuki, Erika, Demo, Susan, Deu, Edgar, Keats, Jonathan, Arastu-Kapur, Shirin, Bergsagel, P. Leif, Bennett, Mark K., Kirk, Christopher J.
Publicado em 2011

RHAMM Is a Centrosomal Protein That Interacts with Dynein and Maintains Spindle Pole Stability

Por Maxwell, Christopher A., Keats, Jonathan J., Crainie, Mary, Sun, Xuejun, Yen, Tim, Shibuya, Ellen, Hendzel, Michael, Chan, Gordon, Pilarski, Linda M.
Publicado em 2003

Xbp1s-Negative Tumor B Cells and Pre-Plasmablasts Mediate Therapeutic Proteasome Inhibitor Resistance in Multiple Myeloma

Por Leung-Hagesteijn, Chungyee, Erdmann, Natalie, Cheung, Grace, Keats, Jonathan J, Stewart, A Keith, Reece, Donna, Chung, Kim Chan, Tiedemann, Rodger E
Publicado em 2013

Non-redundant and complementary functions of adaptor proteins TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling

Por Vallabhapurapu, Sivakumar, Matsuzawa, Atsushi, Zhang, WeiZhou, Tseng, Ping-Hui, Keats, Jonathan J., Wang, Haopeng, Vignali, Dario A. A., Bergsagel, P. Leif, Karin, Michael
Publicado em 2008

Identification of a potent natural triterpenoid inhibitor of proteosome chymotrypsin-like activity and NF-κB with antimyeloma activity in vitro and in vivo

Por Tiedemann, Rodger E., Schmidt, Jessica, Keats, Jonathan J., Shi, Chang-Xin, Zhu, Yuan Xiao, Palmer, Stephen E., Mao, Xinliang, Schimmer, Aaron D., Stewart, A. Keith
Publicado em 2009

Expression and phosphorylation of the AS160_v2 splice variant supports GLUT4 activation and the Warburg effect in multiple myeloma

Por Cheng, Javelin C, McBrayer, Samuel K, Coarfa, Cristian, Dalva-Aydemir, Sevim, Gunaratne, Preethi H, Carpten, John D, Keats, Jonathan K, Rosen, Steven T, Shanmugam, Mala
Publicado em 2013

MAGE-A inhibit apoptosis and promote proliferation in multiple myeloma through regulation of BIM and p21(Cip1)

Por Mei, Anna Huo-Chang, Tung, Kaity, Han, Jessie, Perumal, Deepak, Laganà, Alessandro, Keats, Jonathan, Auclair, Daniel, Chari, Ajai, Jagannath, Sundar, Parekh, Samir, Cho, Hearn Jay
Publicado no Oncotarget (2020)

RNAi screen of the druggable genome identifies modulators of proteasome inhibitor sensitivity in myeloma including CDK5

Por Zhu, Yuan Xiao, Tiedemann, Rodger, Shi, Chang-Xin, Yin, Holly, Schmidt, Jessica E., Bruins, Laura A., Keats, Jonathan J., Braggio, Esteban, Sereduk, Chris, Mousses, Spyro, Stewart, A. Keith
Publicado em 2011

Promiscuous Rearrangements of the MYC Locus Hijack Enhancers and Super-Enhancers to Dysregulate MYC Expression in Multiple Myeloma

Por Affer, Maurizio, Chesi, Marta, Chen, Wei-Dong G., Keats, Jonathan J., Demchenko, Yulia N., Roschke, Anna V., Van Wier, Scott, Fonseca, Rafael, Bergsagel, P. Leif, Kuehl, W. Michael
Publicado em 2014

Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients

Por Keats, Jonathan J., Maxwell, Christopher A., Taylor, Brian J., Hendzel, Michael J., Chesi, Marta, Bergsagel, P. Leif, Larratt, Loree M., Mant, Michael J., Reiman, Tony, Belch, Andrew R., Pilarski, Linda M.
Publicado em 2005

Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities

Por Braggio, Esteban, Dogan, Ahmet, Keats, Jonathan J, Chng, Wee J, Huang, Gaofeng, Matthews, Julie M, Maurer, Matthew J, Law, Mark E, Bosler, David S, Barrett, Michael, Lossos, Izidore S, Witzig, Thomas, Fonseca, Rafael
Publicado em 2012

Comprehensive molecular profiling of 718 Multiple Myelomas reveals significant differences in mutation frequencies between African and European descent cases

Por Manojlovic, Zarko, Christofferson, Austin, Liang, Winnie S., Aldrich, Jessica, Washington, Megan, Wong, Shukmei, Rohrer, Daniel, Jewell, Scott, Kittles, Rick A., Derome, Mary, Auclair, Daniel, Craig, David Wesley, Keats, Jonathan, Carpten, John D.
Publicado no PLoS Genet (2017)

The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma

Por Longo, Joseph, Smirnov, Petr, Li, Zhihua, Branchard, Emily, van Leeuwen, Jenna E., Licht, Jonathan D., Haibe-Kains, Benjamin, Andrews, David W., Keats, Jonathan J., Pugh, Trevor J., Trudel, Suzanne, Penn, Linda Z.
Publicado no Leukemia (2020)

High-Resolution Genomic Analysis in Waldenström’s Macroglobulinemia Identifies Disease-Specific and Common Abnormalities with Marginal Zone Lymphomas

Por Braggio, Esteban, Keats, Jonathan J., Leleu, Xavier, Van Wier, Scott, Jimenez-Zepeda, Victor Hugo, Schop, Roelandt F. J., Chesi, Marta, Barrett, Michael, Stewart, Alexander Keith, Dogan, Ahmet, Bergsagel, Peter Leif, Ghobrial, Irene M., Fonseca, Rafael
Publicado em 2009

CNV Radar: an improved method for somatic copy number alteration characterization in oncology

Por Soong, David, Stratford, Jeran, Avet-Loiseau, Herve, Bahlis, Nizar, Davies, Faith, Dispenzieri, Angela, Sasser, A. Kate, Schecter, Jordan M., Qi, Ming, Brown, Chad, Jones, Wendell, Keats, Jonathan J., Auclair, Daniel, Chiu, Christopher, Powers, Jason, Schaffer, Michael
Publicado no BMC Bioinformatics (2020)

The CCND1 c.870G risk allele is enriched in individuals of African ancestry with plasma cell dyscrasias

Por Baughn, Linda B., Li, Zhuo, Pearce, Kathryn, Vachon, Celine M., Polley, Mei-Yin, Keats, Jonathan, Elhaik, Eran, Baird, Michael, Therneau, Terry, Cerhan, James R., Bergsagel, P. Leif, Dispenzieri, Angela, Rajkumar, S. Vincent, Asmann, Yan W., Kumar, Shaji
Publicado no Blood Cancer J (2020)

Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition

Por Mohan, Pooja, Castellsague, Joan, Jiang, Jihong, Allen, Kristi, Chen, Helen, Nemirovsky, Oksana, Spyra, Melanie, Hu, Kaiji, Kluwe, Lan, Pujana, Miguel Angel, Villanueva, Alberto, Mautner, Victor F., Keats, Jonathan J., Dunn, Sandra E., Lazaro, Conxi, Maxwell, Christopher A.
Publicado em 2013